Finland· FI-REL-REL50585

Segluromet

A metformin and ertugliflozin product containing metformin hydrochloride + ertugliflozin l-pyroglutamic acid, registered in Finland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC A10BD23

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSeglurometATCA10BD23REGISTER NO.FI-REL-REL50585PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Metformin and ertugliflozin is registered in 8 of 19 countries.

Countries holding a registration under ATC A10BD23 (metformin and ertugliflozin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 5 of them publish a price we can compare per daily dose

Metformin and ertugliflozin · ATC A10BD23

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Metformin hydrochloride + Ertugliflozin L-pyroglutamic acid
Manufacturer
Merck Sharp & Dohme B.V.
Country
Finland (FI)
ATC code
A10BD23
ATC class
Metformin and ertugliflozin
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Metformin and ertugliflozin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and ertugliflozin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cddef1af-002d-42b0-a845-58cd7a90b481
GET /v1/drugs/cddef1af-002d-42b0-a845-58cd7a90b481?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "2",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": "7.5 mg / 850 mg",
  "atc_label": "metformiini ja ertugliflotsiini",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/18/1265/015-021, 31",
  "fimea_rel_id": "REL50585",
  "authorised_at": "2018-03-23"
}

See everything about metformin and ertugliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.